Honokiol

2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol

35354-74-6

3′,5-Di-2-propenyl-[1,1′-biphenyl]-2,4′-diol

3′,5-Diallyl-2,4′-biphenyldiol

3′,5-Diallyl-2,4′-biphenyldiol

3′,5-Diallyl-2,4′-biphényldiol

3′,5-Diallylbiphenyl-2,4′-diol

5,3′-DIALLYL-2,4′-DIHYDROXYBIPHENYL

[1,1′-Biphenyl]-2,4′-diol, 3′,5-di-2-propen-1-yl-

Honokiol

[Wiki]

MFCD00016674

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,3-dimethylbutanoic acid

-Diallyl-2,4ʹ

-dihydroxydiphenyl, VEGFR Tyrosine Kinase Inhibitor XIX, VEGFR2 Kinase Inhibitor XV

11513CCO0N

1352608-82-2

2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol

2-(4-oxidanyl-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol

2-[4-hydroxy-3-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol

3,5′-diallyl-4,2′-dihydroxybiphenyl

3′,3′-Diallyl-4,6′-dihydroxybiphenyl

3′,5-bis(prop-2-en-1-yl)-[1,1′-biphenyl]-2,4′-diol

3′,5-di(prop-2-en-1-yl)biphenyl-2,4′-diol

3′,5-di-2-propen-1-yl-[1,1′-biphenyl]-2,4′-diol

3′,5-diallyl-[1,1′-biphenyl]-2,4′-diol

3′,5-Dipropenyl-(1,1′-biphenyl)-2,4′-diol

4-(2-hydroxy-5-prop-2-enylphenyl)-2-prop-2-enylphenol

4-allyl-2-(3-allyl-4-hydroxy-phenyl)phenol

4-allyl-2-(3-allyl-4-hydroxyphenyl)phenol

4-phenyl-6,6-bis(prop-2-enyl)cyclohexa-1,3-diene-1,3-diol

5,3-Diallyl-2,4-dihydroxybiphenyl

5,3ʹ

5,3′-Diallyl-biphenyl-2,4′-diol

5,3″-Diallyl-biphenyl-2,4″-diol

564-73-8

947686-05-7

95%

98%

[1,1′-Biphenyl]-2,4′-diol, 3′,5-di-2-propenyl-

ACE2_HUMAN

Angiotensin-converting enzyme 2

BB_NC-1461

Cannabinoid receptor 2

CNR2_HUMAN

GPVI_HUMAN

Honokiol (NSC 293100)

NSC 293100;NSC293100;NSC-293100

Platelet glycoprotein VI

Podocarpa-8,11,13-triene-3β,12-diol, 13-isopropyl-

SIR3_HUMAN

SMP2_000040

Spike glycoprotein

SPIKE_SARS2

TIM10_YEAST